FUNI · Hypha Labs, Inc.
$0.01
+0.00 (+3.33%)
At close · Aug 28
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, our balance of cash on hand was $5,110, and we had negative working capital of $1,577,350 and an accumulated deficit of $24,996,836 resulting from recurring losses. These factors raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$1.52M
Shares
163.90M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| A. Stone Douglass | President and Chief Executive Officer | Appointed | 2024-03-01 |
| Bruce Raben | director | Resigned | 2023-05-03 |
| A. Stone Douglass | Chief Financial Officer | Appointed | 2021-08-18 |
| Todd Denkin | President | Appointed | 2021-07-07 |
| A. Stone Douglass | Board of Directors | Appointed | 2021-07-07 |
| Todd Peterson | Chief Financial Officer, Secretary and Treasurer | Resigned | 2021-06-22 |
| Edmond A. DeFrank | director | Resigned | 2021-06-04 |
| Kyle Remenda | Chief Executive Officer | Resigned | 2020-07-06 |
| Bruce Raben | Chairman of the Board | Appointed | 2020-02-03 |
| Edmond A. DeFrank | Director | Appointed | 2020-02-03 |